<VariationArchive VariationID="2179378" VariationName="NM_000182.5(HADHA):c.2167_2168dup (p.Tyr724fs)" VariationType="Duplication" Accession="VCV002179378" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-29" DateCreated="2023-02-08" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1919775" VariationID="2179378">
      <GeneList>
        <Gene Symbol="GAREM2" FullName="GRB2 associated regulator of MAPK1 subtype 2" GeneID="150946" HGNC_ID="HGNC:27172" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>2p23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="26173088" stop="26204304" display_start="26173088" display_stop="26204304" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="26395959" stop="26412531" display_start="26395959" display_stop="26412531" Strand="+" />
          </Location>
          <OMIM>617999</OMIM>
        </Gene>
        <Gene Symbol="HADHA" FullName="hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha" GeneID="3030" HGNC_ID="HGNC:4801" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>2p23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="26190635" stop="26244632" display_start="26190635" display_stop="26244632" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="26413503" stop="26467593" display_start="26413503" display_stop="26467593" Strand="-" />
          </Location>
          <OMIM>600890</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000182.5(HADHA):c.2167_2168dup (p.Tyr724fs)</Name>
      <CanonicalSPDI>NC_000002.12:26191373:AGA:AGAGA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>2p23.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="26191373" stop="26191374" display_start="26191373" display_stop="26191374" variantLength="2" positionVCF="26191373" referenceAlleleVCF="C" alternateAlleleVCF="CAG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="26414242" stop="26414243" display_start="26414242" display_stop="26414243" variantLength="2" positionVCF="26414242" referenceAlleleVCF="C" alternateAlleleVCF="CAG" />
      </Location>
      <ProteinChange>Y724fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007121.2" sequenceAccession="NG_007121" sequenceVersion="2" change="g.58247_58248dup">
            <Expression>NG_007121.2:g.58247_58248dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.26191375_26191376dup" Assembly="GRCh38">
            <Expression>NC_000002.12:g.26191375_26191376dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.26414244_26414245dup" Assembly="GRCh37">
            <Expression>NC_000002.11:g.26414244_26414245dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000182.5" sequenceAccession="NM_000182" sequenceVersion="5" change="c.2167_2168dup" MANESelect="true">
            <Expression>NM_000182.5:c.2167_2168dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000173.2" sequenceAccession="NP_000173" sequenceVersion="2" change="p.Tyr724fs">
            <Expression>NP_000173.2:p.Tyr724fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_747" sequenceAccession="LRG_747">
            <Expression>LRG_747:g.58247_58248dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_747t1" sequenceAccession="LRG_747t1">
            <Expression>LRG_747t1:c.2167_2168dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_747p1" sequenceAccession="LRG_747p1" change="p.Tyr724fs">
            <Expression>LRG_747p1:p.Tyr724fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000182.5(HADHA):c.2167_2168dup (p.Tyr724fs) AND multiple conditions" Accession="RCV002591939" Version="2">
        <ClassifiedConditionList TraitSetID="39862">
          <ClassifiedCondition DB="MedGen" ID="C3711645">Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1969443">Mitochondrial trifunctional protein deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-10-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-10-28" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-08" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="39862" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9419" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Mitochondrial trifunctional protein deficiency</ElementValue>
                <XRef ID="MONDO:0012172" DB="MONDO" />
                <XRef ID="237999008" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">TFP</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3684" />
                <XRef ID="3684" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Long-chain hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency and trifunctional protein (TFP) deficiency are caused by impairment of mitochondrial TFP. TFP has three enzymatic activities – long-chain enoyl-CoA hydratase, long-chain 3-hydroxyacyl-CoA dehydrogenase, and long-chain 3-ketoacyl-CoA thiolase. In individuals with LCHAD deficiency, there is isolated deficiency of long-chain 3-hydroxyacyl-CoA dehydrogenase, while deficiency of all three enzymes occurs in individuals with TFP deficiency. Individuals with TFP deficiency can present with a severe-to-mild phenotype, while individuals with LCHAD deficiency typically present with a severe-to-intermediate phenotype. Neonates with the severe phenotype present within a few days of birth with hypoglycemia, hepatomegaly, encephalopathy, and often cardiomyopathy. The intermediate phenotype is characterized by hypoketotic hypoglycemia precipitated by infection or fasting in infancy. The mild (late-onset) phenotype is characterized by myopathy and/or neuropathy. Long-term complications include peripheral neuropathy and retinopathy.</Attribute>
                <XRef ID="NBK583531" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">36063482</ID>
                <ID Source="BookShelf">NBK583531</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C16-OH-C18-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, LCHAD/TFP: C16-OH Elevated +/-C18-OH, 2022</CitationText>
              </Citation>
              <XRef ID="746" DB="Orphanet" />
              <XRef ID="C1969443" DB="MedGen" />
              <XRef ID="MONDO:0012172" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS609015" DB="OMIM" />
            </Trait>
            <Trait ID="15869" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">LCHAD Deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Deficiency of long-chain 3-hydroxyacyl-coenzyme A dehydrogenase</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency</ElementValue>
                <XRef ID="MONDO:0012173" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Long-chain hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency and trifunctional protein (TFP) deficiency are caused by impairment of mitochondrial TFP. TFP has three enzymatic activities – long-chain enoyl-CoA hydratase, long-chain 3-hydroxyacyl-CoA dehydrogenase, and long-chain 3-ketoacyl-CoA thiolase. In individuals with LCHAD deficiency, there is isolated deficiency of long-chain 3-hydroxyacyl-CoA dehydrogenase, while deficiency of all three enzymes occurs in individuals with TFP deficiency. Individuals with TFP deficiency can present with a severe-to-mild phenotype, while individuals with LCHAD deficiency typically present with a severe-to-intermediate phenotype. Neonates with the severe phenotype present within a few days of birth with hypoglycemia, hepatomegaly, encephalopathy, and often cardiomyopathy. The intermediate phenotype is characterized by hypoketotic hypoglycemia precipitated by infection or fasting in infancy. The mild (late-onset) phenotype is characterized by myopathy and/or neuropathy. Long-term complications include peripheral neuropathy and retinopathy.</Attribute>
                <XRef ID="NBK583531" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6867" />
                <XRef ID="6867" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Long Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">36063482</ID>
                <ID Source="BookShelf">NBK583531</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C16-OH-C18-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, LCHAD/TFP: C16-OH Elevated +/-C18-OH, 2022</CitationText>
              </Citation>
              <XRef ID="5" DB="Orphanet" />
              <XRef ID="C3711645" DB="MedGen" />
              <XRef ID="MONDO:0012173" DB="MONDO" />
              <XRef Type="MIM" ID="609016" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="6185057" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="7817335|MedGen:C1969443;CN074230" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003494866" DateUpdated="2024-02-28" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the HADHA protein in which other variant(s) (p.Thr745Serfs*8) have been determined to be pathogenic (Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This variant has not been reported in the literature in individuals affected with HADHA-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Tyr724Cysfs*7) in the HADHA gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 40 amino acid(s) of the HADHA protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HADHA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.26414242_26414243insAG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1969443" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN074230" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="6185057" TraitType="Disease" MappingType="XRef" MappingValue="C1969443" MappingRef="MedGen">
        <MedGen CUI="C1969443" Name="Mitochondrial trifunctional protein deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6185057" TraitType="Disease" MappingType="XRef" MappingValue="CN074230" MappingRef="MedGen">
        <MedGen CUI="C3711645" Name="Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

